Research Article

Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors

Volume: 27 Number: 1 April 30, 2025
EN TR

Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors

Abstract

Aim: This study aimed to evaluate the prevalence of gastrointestinal (GI) symptoms during pregnancy and identify hormonal, nutritional, and lifestyle factors contributing to their severity. Material and Methods: The study was conducted involving 612 pregnant women aged 20 to 40 years, with gestational ages between 5 and 36 weeks. Participants were categorized into three groups based on their trimester. GI symptoms were assessed using the gastrointestinal symptom rating scale (GSRS). A structured questionnaire was used to collect data on demographic characteristics, obstetric history, prior GI conditions, and lifestyle factors. Results: The study found that indigestion (77.6%, n=475), reflux (68.5%, n=419), and abdominal pain (69.9%, n=428) were the most common GI symptoms reported. While indigestion (78.4%, n=171) followed by nausea (76.1%, n=166) was the most common symptoms in the first trimester, abdominal pain (78.1%, n=171) and reflux (76.3%, n=167) were most frequent in the second trimester, In the third trimester, indigestion (81.1%, n=142) was again the most common symptom, followed by reflux (76.6%, n=134). High GSRS scores were found to be significantly associated with excessive tea consumption (OR: 4.22, 95% CI: 1.44-12.35, p<0.001), employment status (OR: 2.32, 95% CI: 1.63-3.32, p<0.001), and TSH levels (OR: 1.26, 95% CI: 1.13-1.41, p<0.001). Conclusion: GI symptoms are highly prevalent during pregnancy and are influenced by modifiable factors such as tea consumption, weight gain, and work-related stress. Monitoring thyroid function, managing weight, reducing tea intake, and addressing stress may help alleviate these symptoms, thereby improving the quality of life for pregnant women.

Keywords

References

  1. Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know?. Ann Gastroenterol. 2018;31(4):385-94.
  2. Longo SA, Moore RC, Canzoneri BJ, Robichaux A. Gastrointestinal conditions during pregnancy. Clin Colon Rectal Surg. 2010;23(2):80-9.
  3. Patrick SK, Schneider KM. Gastrointestinal disorders in pregnancy. In: Olsen M, editor. Obstetric care. Cambridge University Press; 2017. p.375-86.
  4. Zielinski R, Searing K, Deibel M. Gastrointestinal distress in pregnancy: prevalence, assessment, and treatment of 5 common minor discomforts. J Perinat Neonatal Nurs. 2015;29(1):23-31.
  5. Parangi S, Levine D, Henry A, Isakovich N, Pories S. Surgical gastrointestinal disorders during pregnancy. Am J Surg. 2007;193(2):223-32.
  6. Boregowda G, Shehata HA. Gastrointestinal and liver disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2013;27(6):835-53.
  7. Liu C, Zhao G, Qiao D, Wang L, He Y, Zhao M, et al. Emerging progress in nausea and vomiting of pregnancy and hyperemesis gravidarum: challenges and opportunities. Front Med (Lausanne). 2022;8:809270.
  8. Demirel F, Turkay Ü. The effect of inflammatory markers in the hemogram parameters of pregnant women with thyroid disease on obstetric and neonatal outcomes. Duzce Med J. 2023;25(3):231-5.

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Early Pub Date

March 24, 2025

Publication Date

April 30, 2025

Submission Date

October 13, 2024

Acceptance Date

February 25, 2025

Published in Issue

Year 2025 Volume: 27 Number: 1

APA
Körpe, B., Kose, C., Mermi, S., Demir Çendek, B., Ergörün, S. K., Erdoğan, K., & Keskin, H. L. (2025). Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors. Duzce Medical Journal, 27(1), 35-40. https://doi.org/10.18678/dtfd.1565941
AMA
1.Körpe B, Kose C, Mermi S, et al. Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors. Duzce Med J. 2025;27(1):35-40. doi:10.18678/dtfd.1565941
Chicago
Körpe, Büşra, Caner Kose, Sümeyye Mermi, et al. 2025. “Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors”. Duzce Medical Journal 27 (1): 35-40. https://doi.org/10.18678/dtfd.1565941.
EndNote
Körpe B, Kose C, Mermi S, Demir Çendek B, Ergörün SK, Erdoğan K, Keskin HL (April 1, 2025) Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors. Duzce Medical Journal 27 1 35–40.
IEEE
[1]B. Körpe et al., “Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors”, Duzce Med J, vol. 27, no. 1, pp. 35–40, Apr. 2025, doi: 10.18678/dtfd.1565941.
ISNAD
Körpe, Büşra - Kose, Caner - Mermi, Sümeyye - Demir Çendek, Büşra - Ergörün, Samet Kutluay - Erdoğan, Kadriye - Keskin, Hüseyin Levent. “Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors”. Duzce Medical Journal 27/1 (April 1, 2025): 35-40. https://doi.org/10.18678/dtfd.1565941.
JAMA
1.Körpe B, Kose C, Mermi S, Demir Çendek B, Ergörün SK, Erdoğan K, Keskin HL. Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors. Duzce Med J. 2025;27:35–40.
MLA
Körpe, Büşra, et al. “Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors”. Duzce Medical Journal, vol. 27, no. 1, Apr. 2025, pp. 35-40, doi:10.18678/dtfd.1565941.
Vancouver
1.Büşra Körpe, Caner Kose, Sümeyye Mermi, Büşra Demir Çendek, Samet Kutluay Ergörün, Kadriye Erdoğan, Hüseyin Levent Keskin. Gastrointestinal Symptoms in Pregnancy: The Influence of Thyroid-Stimulating Hormone and Modifiable Risk Factors. Duzce Med J. 2025 Apr. 1;27(1):35-40. doi:10.18678/dtfd.1565941